Effectiveness of Ultra-Low Tidal Volume Ventilation in Patients With COVID-19–Related ARDS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial
Lancet Respir Med 2023 Jul 12;[EPub Ahead of Print], JC Richard, N Terzi, H Yonis, F Chorfa, F Wallet, C Dupuis, L Argaud, B Delannoy, G Thiery, C Pommier, P Abraham, M Muller, F Sigaud, G Rigault, E Joffredo, M Mezidi, B Souweine, L Baboi, H Serrier, M Rabilloud, L BitkerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.